Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets

被引:2
|
作者
Nisar, Ayesha [1 ,2 ,3 ]
Khan, Sawar [4 ,5 ]
Li, Wen [6 ]
Hu, Li [1 ,2 ,3 ]
Samarawickrama, Priyadarshani Nadeeshika [1 ,2 ,3 ]
Gold, Naheemat Modupeola [1 ,2 ,3 ]
Zi, Meiting [1 ,3 ]
Mehmood, Sardar Azhar [7 ]
Miao, Jiarong [8 ]
He, Yonghan [1 ,2 ,3 ]
机构
[1] Chinese Acad Sci, Kunming Inst Zool, Key Lab Genet Evolut & Anim Models, KIZ CUHK Joint Lab Bioresources & Mol Res Common D, Kunming, Yunnan, Peoples R China
[2] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China
[3] Chinese Acad Sci, Kunming Inst Zool, Key Lab Hlth Aging Res Yunnan Prov, Kunming, Yunnan, Peoples R China
[4] Cent South Univ, Sch Life Sci, Dept Cell Biol, Changsha, Hunan, Peoples R China
[5] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan
[6] Dali Univ, Affiliated Hosp 2, Peoples Hosp Yunnan Prov 3, Dept Endocrinol, Kunming, Yunnan, Peoples R China
[7] Hazara Univ, Dept Zool, Mansehra, Pakistan
[8] Kunming Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Kunming, Yunnan, Peoples R China
来源
MEDCOMM | 2024年 / 5卷 / 11期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
age-related disease; aging; hypoxia; mechanism; therapeutic target; NF-KAPPA-B; CHRONIC INTERMITTENT HYPOXIA; INDUCED TAU PHOSPHORYLATION; ALTITUDE CEREBRAL EDEMA; OBSTRUCTIVE SLEEP-APNEA; SENESCENT CELLS; CELLULAR SENESCENCE; ALZHEIMERS-DISEASE; INDUCIBLE FACTORS; STEM-CELLS;
D O I
10.1002/mco2.786
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aging is a complex biological process characterized by the gradual decline of cellular functions, increased susceptibility to diseases, and impaired stress responses. Hypoxia, defined as reduced oxygen availability, is a critical factor that influences aging through molecular pathways involving hypoxia-inducible factors (HIFs), oxidative stress, inflammation, and epigenetic modifications. This review explores the interconnected roles of hypoxia in aging, highlighting how hypoxic conditions exacerbate cellular damage, promote senescence, and contribute to age-related pathologies, including cardiovascular diseases, neurodegenerative disorders, cancer, metabolic dysfunctions, and pulmonary conditions. By examining the molecular mechanisms linking hypoxia to aging, we identify key pathways that serve as potential therapeutic targets. Emerging interventions such as HIF modulators, antioxidants, senolytics, and lifestyle modifications hold promise in mitigating the adverse effects of hypoxia on aging tissues. However, challenges such as the heterogeneity of aging, lack of reliable biomarkers, and safety concerns regarding hypoxia-targeted therapies remain. This review emphasizes the need for personalized approaches and advanced technologies to develop effective antiaging interventions. By integrating current knowledge, this review provides a comprehensive framework that underscores the importance of targeting hypoxia-induced pathways to enhance healthy aging and reduce the burden of age-related diseases. Aging involves the decline of cellular functions and increased disease susceptibility. Hypoxia, or reduced oxygen availability, accelerates aging by influencing pathways like hypoxia-inducible factors (HIFs), oxidative stress, and inflammation. This review highlights how hypoxia exacerbates cellular damage, promotes senescence, and contributes to age-related diseases. Emerging therapies, such as HIF modulators and senolytics, show promise in mitigating hypoxia's impact on aging. image
引用
收藏
页数:27
相关论文
共 50 条
  • [21] Hypoxia: molecular pathophysiological mechanisms in human diseases
    Ylenia Della Rocca
    Luigia Fonticoli
    Thangavelu Soundara Rajan
    Oriana Trubiani
    Sergio Caputi
    Francesca Diomede
    Jacopo Pizzicannella
    Guya Diletta Marconi
    Journal of Physiology and Biochemistry, 2022, 78 : 739 - 752
  • [22] Immunological mechanisms and therapeutic targets of fatty liver diseases
    Hua Wang
    Wajahat Mehal
    Laura E. Nagy
    Yaron Rotman
    Cellular & Molecular Immunology, 2021, 18 : 73 - 91
  • [23] Editorial: The molecular mechanisms and therapeutic targets of atherosclerosis
    Gualtierotti, Roberta
    Ruscica, Massimiliano
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
  • [24] Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis
    Anderson, Nora
    Borlak, Juergen
    PHARMACOLOGICAL REVIEWS, 2008, 60 (03) : 311 - 357
  • [25] Immunological mechanisms and therapeutic targets of fatty liver diseases
    Wang, Hua
    Mehal, Wajahat
    Nagy, Laura E.
    Rotman, Yaron
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (01) : 73 - 91
  • [26] Circular RNAs in liver diseases: Mechanisms and therapeutic targets
    Fu, Li-Yun
    Wang, Shu-Wei
    Hu, Meng-Yuan
    Jiang, Zhen-Luo
    Shen, Li-Li
    Zhou, Yu-Ping
    Guo, Jun-Ming
    Hu, Yao-Ren
    LIFE SCIENCES, 2021, 264
  • [27] Redox regulation: mechanisms, biology and therapeutic targets in diseases
    Li, Bowen
    Ming, Hui
    Qin, Siyuan
    Nice, Edouard C.
    Dong, Jingsi
    Du, Zhongyan
    Huang, Canhua
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [28] Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals
    Abdolmaleky, Hamid Mostafavi
    Zhou, Jin-Rong
    NUTRIENTS, 2023, 15 (15)
  • [29] Epigenetic modifications and emerging therapeutic targets in cardiovascular aging and diseases
    Qiu, Yurou
    Xu, Qing
    Xie, Peichen
    He, Chenshuang
    Li, Qiuchan
    Yao, Xin
    Mao, Yang
    Wu, Xiaoqian
    Zhang, Tiejun
    PHARMACOLOGICAL RESEARCH, 2025, 211
  • [30] Emerging molecular mechanisms and genetic targets for developing novel therapeutic strategies for treating bladder diseases
    Zoqlam, Randa
    Lazauskaite, Sandra
    Glickman, Scott
    Zaitseva, Lyubov
    Ilie, Petre-Cristian
    Qi, Sheng
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 173